The Effects of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy

Status unconfirmed · Phase 3

Conditions studied: Diabetic Neuropathies, Pain, Neuralgia

In brief

This study is intended to demonstrate that exposure to a high intensity, DC electromagnetic field, as supplied by the investigational device known as the Molecular Magnetic Energizer (MME), will create a clinically meaningful improvement in pain and nerve dysfunction in the feet of patients with diabetic peripheral neuropathy (DPN).

Key facts

Study ID
NCT00134524
Run by
Advanced Magnetic Research Institute International
People needed
100
Starts
2005-07-01
Expected to finish
2008-01-01
Last updated by the study team
2007-07-10

Who can join

Age: 18 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.